Keyphrases
CXCL10
100%
Neuroinflammation
85%
Lipopolysaccharide-induced
84%
Lipopolysaccharide
76%
Astroglial Cells
63%
Chemokine (C-C motif) Ligand 2 (CCL2)
50%
Inflammatory Pathways
44%
Chemokine Expression
44%
Ovariectomy
43%
Social Defeat
43%
Inflammation
42%
Interleukin-1β
40%
Weight Gain
39%
Interleukin-6
39%
Paraventricular nucleus
35%
C57BL
35%
Dorsal Vagal Complex
33%
Sickness
33%
Monocyte Chemoattractant protein-1 (MCP-1)
32%
Nicotinic Acetylcholine Receptor (nAChR)
31%
Arcuate nucleus
31%
Inflammatory Chemokines
30%
Neuroimmune Signaling
29%
Chemokines
29%
Behavioral Impairment
29%
Lipopolysaccharide-induced Inflammation
29%
Metabolic Hormones
29%
PAM2
29%
Anti-inflammatory Effect
28%
Neuroimmune Response
27%
Nuclear factor-κB
27%
Liver
26%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
Protective Effect
25%
Mu-opioid Receptor Antagonist
24%
Brain Regions
24%
Spleen
23%
Neuropathic Pain
23%
Anti-inflammatory Activity
23%
Sickness Behavior
23%
Cerebellum
23%
Anxiety-like Behavior
22%
OVX Rats
22%
Whole Brain
22%
Toll-like
22%
Human Astrocytes
21%
NF-B
21%
Positive Allosteric Modulator
21%
Brainstem
20%
Obesity
20%
Neuroscience
CXCL10
84%
Lipopolysaccharide
73%
Chemokine
71%
Astrocyte
53%
Social Defeat
43%
Arcuate Nucleus
39%
Blood Plasma
39%
CCL2
32%
Narcotic Antagonist
31%
Interleukin 6
30%
Anti-Inflammatory
30%
Behavior (Neuroscience)
28%
Interleukin 1
25%
Cerebellum
25%
Glial Fibrillary Acidic Protein
25%
Protein Expression
24%
Leptin
24%
μ-Opioid Receptor
24%
Naltrexone
24%
Hippocampus
24%
TLR 4
23%
Ghrelin
21%
Gamma Interferon Inducible Protein 10
21%
Mood Disorder
20%
Neurological Disorder
20%
Receptor
19%
Alzheimer's Disease
19%
Monocyte Chemotactic Protein 1
19%
Anxiety Disorder
18%
In Vivo
18%
Leptin Receptor
17%
Interferon
16%
In Vitro
14%
Sickness Behavior
14%
Anti-Inflammatory Agent
14%
Neuromelanin
14%
Pervasive Developmental Disorder
14%
Nitric Oxide Synthase
14%
Inducible Nitric Oxide Synthase
14%
Synuclein
14%
Neuroreceptor
14%
Positive Allosteric Modulator
14%
Astrocytoma
14%
Nicotinic Acetylcholine Receptor
14%
Social Behavior
14%
Parkinson's Disease
14%
Hormone Receptor
13%
Necrosis
13%
Messenger RNA
11%
Brainstem
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chemokine
95%
Disease
91%
Lipopolysaccharide
87%
Inflammation
50%
Tumor Necrosis Factor
47%
Nervous System Inflammation
46%
Positive Allosteric Modulator
43%
Cytokine
35%
Interleukin 6
35%
Nicotinic Receptor
31%
Lipopolysaccharide-Induced Inflammation
29%
Anti-Inflammatory Drug
28%
Naltrexone
26%
Interferon
25%
Lipopolysaccharide-Induced Neuroinflammation
24%
Neurologic Disease
22%
Enzyme-Linked Immunosorbent Assay
22%
Antiinflammatory Activity
21%
Neuropathic Pain
21%
Mu Opiate Receptor Antagonist
21%
Gamma Interferon Inducible Protein 10
20%
Narcotic Antagonist
19%
Mood Disorder
17%
Antiinflammatory Agent
16%
Glial Fibrillary Acidic Protein
16%
Interleukin 1
16%
Toll Like Receptor 4
16%
Normal Human
16%
Nitric Oxide Synthase
14%
Ghrelin
14%
Anxiety Disorder
14%
Heavy Metal
14%
HIV
14%
Chemotherapy
14%
Leptin
14%
Inducible Nitric Oxide Synthase
14%
Mouse Model
14%
Pharmacotherapy
14%
Receptor
14%
μ-Opioid Receptor
13%
Alzheimer's Disease
12%
Opiate
11%
Monocyte Chemotactic Protein 1
10%
Oxaliplatin
10%
Duragesic
9%
Immunoglobulin Enhancer Binding Protein
9%
Nuclear Factor
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Western Blot
9%
Neuroprotective Agent
8%